SEC Form 4 · accession 0000357097-16-000159
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas J Swirsky
Director
Period of report
Jun 22, 2016
Accepted (ET)
Jun 23, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2,F1 | $0.95 | Jun 22, 2016 | A | 36,000 | A | — | Jun 22, 2026 | Common Stock | 36,000 | 36,000 | D |
Explanation of responses
- F1With respect to all 36,000 options, these options vest 100% and become exercisable on the earlier of (x) June 22, 2017 or (y) the date of Fibrocell's 2017 Annual Meeting of Stockholders, subject to the grantee's continued service through the vesting date.
- F2The options were issued in connection with the reporting person's service to the Company as a member of its Board of Directors.